for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Shanghai Junshi Biosciences Enters Agreement With Eli Lilly And Company

May 4 (Reuters) - Shanghai Junshi Biosciences Co Ltd :

* ENTERED RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH ELI LILLY AND COMPANY

* PARTIES WILL COLLABORATE IN RESEARCH RELATING TO SARS-COV-2 NEUTRALIZING ANTIBODIES

* LILLY GRANTED EXCLUSIVE LICENSE TO MAKE & SELL JUNSHI SARS-COV-2 ANTIBODIES OUTSIDE OF GREATER CHINA

* LILLY WILL PAY TO CO UPFRONT FEE OF US$10 MILLION

* UPON ACHIEVING PRESCRIBED MILESTONE EVENTS, MILESTONE PAYMENTS OF UP TO US$245 MILLION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up